Recovery of PEX1-Gly843Asp peroxisome dysfunction by small-molecule compounds.
A pilot, open label trial assessing the safety and efficacy of betaine in patients with peroxisome
biogenesis disorders, PEX1-Gly843Asp (G843D) genotype, concluded that betaine did not overall
improve peroxisome functions in this 6 month trial at the dosage used (1-14-15).
http://www.ncbi.nlm.nih.gov/pubmed/20212125
Berendse K., et al. 2014: Arginine improves peroxisome functioning in cells from patients with
a mild peroxisome biogenesis disorder.
http://www.ojrd.com/content/8/1/138
Phytanic acid reference
http://www.refsumdisease.org/patients/dietphytanicacidphytol.shtml